The National Committee for Quality Assurance published their 2017 Healthcare Effectiveness Data and Information Set quality measures for colorectal cancer screening, which included Exact Sciences‘ Cologuard.
Cchek, an early cancer detection technology developed by ITUS, has successfully been used to identify the presence of liver cancer.
Long-term use of Takeda Pharmaceutical‘s Entyvio (vedolizumab) may improve quality of life for patients suffering from inflammatory bowel disease, according to two interim reports published in the Journal of Crohn’s and Colitis. A study in Clinical Gastroenterology and Hepatology also found that vedolizumab may improve clinical outcomes for patients suffering from ulcerative colitis, irrespective of treatment history.
More articles on gastroenterology and endoscopy:
Predictive overbooking maximizes endoscopy clinic scheduling: 5 study insights
GI societies advocate for increased coverage of CRC screening, treatment: 4 notes
What is the future of colorectal cancer screening? Still colonoscopy, says Dr. David A. Johnson
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
